Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Feb;23(1):257-69.
doi: 10.1007/s11136-013-0470-1. Epub 2013 Jul 20.

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Collaborators, Affiliations
Multicenter Study

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Jennifer L Hay et al. Qual Life Res. 2014 Feb.

Abstract

Purpose: The National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is a library of question items that enables patient reporting of adverse events (AEs) in clinical trials. This study contributes content validity evidence of the PRO-CTCAE by incorporating cancer patient input of the relevance and comprehensiveness of the item library.

Methods: Cognitive interviews were conducted among patients undergoing chemotherapy or radiation therapy at multiple sites to evaluate comprehension, memory retrieval, judgment, and response mapping related to AE terms (e.g., nausea), attribute terms (regarding frequency, severity, or interference), response options, and recall period. Three interview rounds were conducted with ≥20 patients completing each item per round. Items were modified and retested if ≥3 patients exhibited cognitive difficulties or if experienced by ≤25% patients.

Results: One hundred and twenty-seven patients participated (35% ≤high school, 28% non-white, and 59% female). Most AE terms (63/80) generated no cognitive difficulties. The remaining 17 were modified without further difficulties by Round 3. Terms were comprehended regardless of education level. Attribute terms and response options required no modifications. Patient adherence to recall period (7 days) was improved when the reference period was incorporated.

Conclusions: This study provides evidence confirming comprehension of the US English language versions of items in the PRO-CTCAE library for measuring symptomatic AEs from the patient perspective within the context of cancer treatment. Several minor changes were made to the items to improve item clarity, comprehension, and ease of response judgment. This study helps to establish the content validity of PRO-CTCAE items for patient reporting of AEs during cancer treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for each round of cognitive interviews showing the number of PRO-CTCAE adverse events (AEs) for which items were evaluated in each round, and changes made. Each AE maps to a term in the CTCAE and may be characterized by up to three items representing the attributes of frequency, severity, and/or interference with activities. AE, Adverse Event; CTCAE, Common Terminology Criteria for Adverse Events; PRO-CTCAE, Patient-Reported Outcomes version of the CTCAE

References

    1. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse events of cancer treatment. Semin Radiat Oncol. 2003;13:176–181. - PubMed
    1. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. [Accessed May 20, 2013];Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published May 28, 2009; Revised Version 4.03 June 14, 2010 (Vol. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5....
    1. Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865–869. doi: 10.1056/NEJMp0911494. - DOI - PMC - PubMed
    1. Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7:903–909. doi: 10.1016/S1470-2045(06)70910-X. - DOI - PubMed
    1. Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624–1632. doi: 10.1093/jnci/djp386. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources